Home » Topics » BioWorld Science

BioWorld Science
RSS

Nippon Kayaku R&D pipeline update

Nov. 20, 1996

New macrocyclic immunosuppressants from Abbott

Nov. 20, 1996

Mallinckrodt describes diagnostic agents for serotonin-related disorders

Nov. 19, 1996

Cysteine protease inhibitors revealed by Takeda

Nov. 19, 1996

Hycamtin approved in Europe

Nov. 19, 1996

Antineoplastic PTP inhibitors disclosed by Department of Health & Human Services

Nov. 19, 1996

RCT reports novel circular oligonucleotides

Nov. 19, 1996

Completion of phase IIa trials with CytoTAb in sepsis

Nov. 19, 1996

New anti-HIV agents discovered by Hoechst

Nov. 19, 1996

NO donors reported for cancer chemotherapy

Nov. 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...